Search - tctmd.com

Displaying 121 - 140 of 463

Sort: Relevancy | Date

Presentation ACC 2024

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

Presenter: Martin S. Maron

April 08, 2024

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News ACC 2024

ADHD Meds Linked to Cardiomyopathy in Young Adults

Todd Neale

April 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Caitlin E. Cox

March 18, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Presenter: Adam B. Greenbaum

March 05, 2024

Presentation THT 2024

CMR in Ischemic Cardiomyopathy

Presenter: Jonathan Weinsaft

March 05, 2024

Presentation THT 2024

CMR in Genetic Cardiomyopathy

Presenter: Chetan Shenoy

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Presenter: Akhil Narang

March 05, 2024

Presentation THT 2024

Utilization of 12-Lead ECG in Diagnostics and Management of Cardiomyopathy

Presenter: Christopher Haggerty

March 05, 2024

Presentation THT 2024

Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome

Presenter: Davis Kimaiyo

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation THT 2024

Transcather Approaches to HOCM: From ASA to SESAME

Presenter: Adam B. Greenbaum

March 04, 2024

Advertisement

Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM)

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

ADHD Meds Linked to Cardiomyopathy in Young Adults

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

US Sees a Surge in Cardiomyopathy-Linked Hospital Stays Among Meth Users

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

CMR in Ischemic Cardiomyopathy

CMR in Genetic Cardiomyopathy

Debating the Role of T-TEER in the Sickest Patients

Automated Read of Echocardiogram to Identify Cardiomyopathy and Valvular Heart Disease

Utilization of 12-Lead ECG in Diagnostics and Management of Cardiomyopathy

Use of a Novel Intra-Aortic Entrainment Pump for a Patient With Restrictive Cardiomyopathy and Recurrent Cardiorenal Syndrome

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Transcather Approaches to HOCM: From ASA to SESAME

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content